Literature DB >> 20148044

Acute gastrointestinal illness in New Zealand: information from a survey of community and hospital laboratories.

Rob Lake1, Nicola King, Kerry Sexton, Philippa Bridgewater, Donald Campbell.   

Abstract

AIM: To describe and quantify laboratory testing of faecal samples for enteric pathogens as a component of the reporting pyramid of acute gastrointestinal illness (AGI) in New Zealand.
METHOD: Postal survey of community and hospital laboratories throughout New Zealand conducted in mid-2006, requesting data from the 2005 calendar year.
RESULTS: Of the 47 laboratories eligible for the survey, responses were received from 35 (74%, 16 hospital laboratories, 12 community laboratories, five hospital and community laboratories, and two Public Health Laboratories). Based on survey data and extrapolation it was estimated that approximately 250,000 faecal samples were received by New Zealand laboratories in 2005. The majority of these (77%) were requested by primary healthcare providers on people in the community. Routine testing of these samples would include bacteria (Salmonella, Shigella, Campylobacter, Yersinia) and parasites (Cryptosporidium, Giardia) and (depending principally on the age of the patient) rotavirus. Testing for other pathogens was comparatively infrequent. The frequency of detection of a pathogen in community samples was estimated as approximately 20%.
CONCLUSION: The positivity rate of 20% for faecal samples from people in the community is consistent with overseas results. Although there was considerable variation in the testing methods employed by the laboratories the methods were considered appropriate based on consultation with ESR Public Health and Reference Laboratory staff. These data on the number and type of samples, and positivity rate , will assist in the determination of a reporting pyramid for AGI in New Zealand.

Entities:  

Mesh:

Year:  2009        PMID: 20148044

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  3 in total

1.  Epsilonproteobacteria in humans, New Zealand.

Authors:  Angela J Cornelius; Stephen Chambers; John Aitken; Stephanie M Brandt; Beverley Horn; Stephen L W On
Journal:  Emerg Infect Dis       Date:  2012-03       Impact factor: 6.883

2.  Island-Wide Surveillance of Gastrointestinal Protozoan Infection on Fiji by Expanding Lymphatic Filariasis Transmission Assessment Surveys as an Access Platform.

Authors:  Sung Hye Kim; Milika Rinamalo; Meleresita Rainima-Qaniuci; Nemani Talemaitoga; Mike Kama; Eric Rafai; John H Lowry; Min-Ho Choi; Sung-Tae Hong; Jaco J Verweij; Louise Kelly-Hope; J Russell Stothard
Journal:  Am J Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.345

Review 3.  Neglected tropical diseases of Oceania: review of their prevalence, distribution, and opportunities for control.

Authors:  Kevin Kline; James S McCarthy; Mark Pearson; Alex Loukas; Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2013-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.